4 completed, 1 recruiting. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Biliary Cancer Metastatic: new trials by email Literature Review of Biliary Cancer Metastatic trials Research Report on Biliary Cancer Metastatic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bevacizumab Plus Nab-paclitaxel and Tegafur Gimeracil Oteracil Potassium Capsule (S-1) as Second-line Treatment for Advanced Biliary Tract Cancer: a Phase Ⅱ Clinical Trial Bevacizumab+nab-paclitaxel+tegafur gimeracil oteracil potassium capsule (S-1) - Biliary Cancer Metastatic | Phase 2 | Completed | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 32 | 2026-02-23 | 2026-07-22 |
| mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line Oxaliplatin, 5FU, leucovorin, Oxaliplatin, 5FU, leucovorin/Irinotecan , 5FU, leucovorin, - Biliary Cancer Metastatic | Phase 2 | Recruiting | Seoul National University Bundang Hospital | 130 | 2025-08-27 | 2026-08-14 |
| A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors ZB131 - Solid Tumor, Adult, Pancreatic Ductal; Adenocarcinoma | Phase 1 / Phase 2 | Completed | ZielBio, Inc. | 35 | 2022-01-14 | 2024-01-29 |
| Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients Early palliative care, Routine hospice care - Stage IV Breast Cancer, Stage IV Pancreatic Cancer | Completed | Seoul National University Hospital | 444 | 2016-12-17 | 2021-03-17 | |
| mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line Oxaliplatin,5FU, leucovorin, irinotecan,5FU, leucovorin - Biliary Cancer Metastatic | Phase 2 | Completed | Seoul National University Bundang Hospital | 120 | 2015-07-29 | 2020-12-02 |
Pancreatic Neoplasms (2) · Adenocarcinoma (1) · Biliary Tract Neoplasms (1) · Breast Neoplasms (1) · Colonic Neoplasms (1) · Hematologic Neoplasms (1) · Liver Neoplasms (1) · Lung Neoplasms (1) · Ovarian Neoplasms (1) · Stomach Neoplasms (1)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Pancreatic Diseases (2) · Adnexal Diseases (1) · Biliary Tract Diseases (1) · Breast Diseases (1) · Carcinoma (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
Leucovorin (2) · Fluorouracil (1) · Irinotecan (1) · Oxaliplatin (1) · S 1 (combination) (1)
Seoul National University Bundang Hospital (2) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Seoul National University Hospital (1) · ZielBio, Inc. (1)
South Korea (3) · China (1) · United States (1)
Jin Won Kim (1) · Ramesh Ramanathan, MD (1) · Young Ho Yun, MD-PhD (1)